Cytosorbents Corporation · NASDAQ:CTSO
The Vanguard Group reported a 7.13% stake in Cytosorbents Corporation (Schedule 13G)
Event Dec 31, 2024 · Filed Jan 31, 2025
The Vanguard Group reported a 7.13% stake in Cytosorbents Corporation, 3,899,102 shares, as a passive investor on Dec 31, 2024. Filed Jan 31, 2025 (Schedule 13G).
- Stake
- 7.13%
- Shares
- 3,899,102
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| The Vanguard Group | 7.13% | 3,899,102 |
Source
Related
- Cytosorbents Corporation
- The Vanguard Group
- Cytosorbents Corporation shareholders
- Schedule 13G/A · The Vanguard Group · Apr 30, 2025
- Form 4 · Chan Phillip P. · Sep 16, 2026
- Form 4 · Sobel Alan D. · Sep 16, 2026
- Form 4 · Capponi Vincent · Sep 16, 2026
- Form 4 · Chan Phillip P. · Sep 9, 2026
- Form 4 · Mariani Peter J · Jun 16, 2026